Organon & Co. (OGN) Guidance & Earnings Results

On 2026-02-12 Organon & Co. reaffirmed guidance: "Revenue ~$6.2B, Adjusted EBITDA ~$1.9B for…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OGNOrganon & Co.Follow OGN — free

Drug Manufacturers - General · Healthcare

—

Price chart with a free account

Market cap: 3.6B
P/E TTM: 17.6
Dividend yield: 0.6%
52-week: —
Next earnings: 9 Nov, in 16 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
12 Feb 26	Reaffirmed	Revenue ~$6.2B, Adjusted EBITDA ~$1.9B for FY2026 · full year
10 Nov 25	Lowered	Revenue guidance lowered to $6.200-6.250B; Adj. EBITDA margin ~31.0% · full year
5 Aug 25	Raised	FY25 revenue raised to $6.275-6.375B from prior range (not stated); FY25 adj. EBITDA margin affirmed at 31.0-32.0% · full year

Organon & Co. — questions

What guidance did Organon & Co. give?: On 2026-02-12: "Revenue ~$6.2B, Adjusted EBITDA ~$1.9B for FY2026"
When does Organon & Co. report earnings?: Organon & Co.'s next earnings report is expected on 2026-11-09.

Every figure on this page comes from Organon & Co.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.